Skip to content

The Utility of Telemedicine in the Management of Migraine

The Utility of Telemedicine in the Management of Migraine: A Pilot Study :MK0974-071-00

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01706003
Enrollment
45
Registered
2012-10-15
Start date
2012-10-31
Completion date
2018-10-31
Last updated
2019-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine Headaches

Keywords

Migraine, Headaches, Telemedicine

Brief summary

Patients will be randomly assigned to receive their follow-up care via telemedicine or in-office visits.

Detailed description

After obtaining informed consent, patients will be randomly assigned to receive their follow-up care via telemedicine or in-office visits. All subjects will complete a MIDAS questionnaire and allodynia questionnaire at their initial visit. Follow-up visits will be scheduled at 4-6 weeks, 3, 6, 9 and 12 months. In-person follow-up visits will be conducted in the standard fashion of the current physician's practice, with the initial intake conducted by an ophthalmic technician or resident, followed by the physician visit. Telemedicine visits will be conducted by the physician and recorded. Similar information will be gathered in both groups including: current medications, interim medical and headache history (including visits to the ED or hospitalizations for headache), description of headache, response to treatment (including adverse reactions), allergies, blood pressure and weight. Subjects randomized to telemedicine will be asked to have their blood pressure and weight measured within 5 days of their telemedicine session at a location convenient to them. We will record the length of each visit. Subjects in the in-person group, will be queried about travel time, and the total amount of time for the visit, and any activities missed to attend the visit. We will also ask about other costs associated with attending the office visit, such as child care. At the one-year follow-up visit, subjects will complete the MIDAS, allodynia questionnaire, Modified Group Health Association of America's Consumer Satisfaction scale, and have the opportunity to express their views on the aspect of care received in a semi-structured interview. The follow-up questionnaires may be completed on line (telemedicine group, optional for in-person group) or on paper (in-person group). Headache diaries will be provided on line or may be done on paper, a smartphone, or a computer program of the subject's choosing. All subjects will be able to access the physician by telephone, using MyChart, or with additional non-study visits as needed. Subjects will be responsible for the cost of the medications, treatments prescribed, and laboratory monitoring needed for their condition. Support staff will be available to help set up the video system for subjects assigned to the telemedicine group who are in need of assistance.

Interventions

None listed

Sponsors

Merck Sharp & Dohme LLC
CollaboratorINDUSTRY
University of Texas Southwestern Medical Center
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

• Ages 18 - 89 years * Diagnosis of migraine with or without aura, menstrual migraine, hemiplegic migraine * Able to provide informed consent * Able, in the opinion of the investigator, to reliably perform all aspects of the study * Ownership of or access to a computer and high speed internet Criteria for Exclusion of Subjects: * Age less than 18 years * Headache type is not migraine * No ownership or access to a computer or high speed internet * Unfamiliar with basic computer operations or uncomfortable using a computer * Unwilling to participate * Unable to read English (because of assessment tools) * History of another medical, psychiatric, social or behavioral problem that, in the opinion of the investigator, makes it unlikely that they will be able to complete the study activities. Questions regarding mood and anxiety are asked of all patients as part of their initial evaluation for headache.

Design outcomes

Primary

MeasureTime frameDescription
Assess the Utility of Telemedicine for Follow-up Care in a Headache Medicine PracticeOne YearPercentage of completed scheduled study visits for each group.

Countries

United States

Participant flow

Participants by arm

ArmCount
In-Office Group
People who suffer from Migraine Headaches who own a computer and have internet access and will be treated in the clinician's office for migraine headaches
23
Telemedicine Group
People who suffer from Migraine Headaches who own a computer and have internet access and will be treated via telemedicine for migraine headaches
22
Total45

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up64
Overall StudyNot scheduled30
Overall StudyWithdrawal by Subject20

Baseline characteristics

CharacteristicIn-Office GroupTelemedicine GroupTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
23 Participants22 Participants45 Participants
Migraine Disability Assessment Score (MIDAS)40.5 units on a scale65 units on a scale47.9 units on a scale
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
23 participants22 participants45 participants
Sex: Female, Male
Female
21 Participants22 Participants43 Participants
Sex: Female, Male
Male
2 Participants0 Participants2 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 230 / 22
other
Total, other adverse events
0 / 230 / 22
serious
Total, serious adverse events
0 / 233 / 22

Outcome results

Primary

Assess the Utility of Telemedicine for Follow-up Care in a Headache Medicine Practice

Percentage of completed scheduled study visits for each group.

Time frame: One Year

ArmMeasureValue (NUMBER)
In-Office GroupAssess the Utility of Telemedicine for Follow-up Care in a Headache Medicine Practice87 percentage of scheduled appointments
Telemedicine GroupAssess the Utility of Telemedicine for Follow-up Care in a Headache Medicine Practice92.7 percentage of scheduled appointments

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026